JESSICA MILLS: Open Payments
NPI 1518581644 · FREDERICKSBURG, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$791 in 33 payments from 19 companies in 2025. Trend: 2023 $102 · 2024 $1,280 · 2025 $791
Food & beverage: $770Education: $21
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $122 |
| Janssen Biotech, Inc. | 3 | $99 |
| PFIZER INC. | 4 | $71 |
| GlaxoSmithKline, LLC. | 3 | $64 |
| Daiichi Sankyo Inc. | 2 | $63 |
| ABBVIE INC. | 2 | $51 |
| Pharmacosmos Therapeutics Inc. | 2 | $44 |
| TerSera Therapeutics LLC | 1 | $39 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $30 |
| ACCORD HEALTHCARE, INC. | 1 | $29 |
Products named: ENHERTU, RYBREVANT, LYNPARZA, MONOFERRIC, Xermelo, ELAHERE, OJJAARA, XTANDI.
Industry payments across VA — which companies pay providers there.
